UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-01 | Future report Set alerts | |
| Q2 2022 | 2022-08-15 | 1.14 | 1.14 |
| Q1 2022 | 2022-05-10 | 0.88 | 0.88 |
| Q1 2021 | 2022-05-10 | 0.88 | 0.88 |
| Q4 2021 | 2022-03-02 | 0.23 | 0.23 |
| Q4 2020 | 2022-03-02 | 0.23 | 0.23 |
| Q3 2020 | 2020-11-24 | -0.14 | -0.14 |
| Q2 2020 | 2020-08-31 | -0.07 | -0.07 |
| Q1 2020 | 2020-06-08 | -0.22 | -0.22 |
| Q4 2019 | 2020-03-02 | -0.32 | -0.32 |
| 2016-06-13 | Upgrade | Jefferies Group | Hold to Buy | $19.00 to $11.00 |
| 2016-05-25 | Reiterated Rating | B. Riley | Buy | $12.50 |
| 2016-05-20 | Reiterated Rating | B. Riley | Buy | $12.50 |
| 2016-03-21 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $19.00 to $14.00 |
| 2016-02-09 | Reiterated Rating | Oppenheimer | Outperform | $25.00 to $16.00 |
| 2016-02-09 | Reiterated Rating | Oppenheimer Holdings Inc. | Outperform | $25.00 to $16.00 |
| 2016-01-11 | Lower Price Target | Stifel Nicolaus | Buy | $23.00 to $20.00 |
| 2016-01-03 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-01-02 | Reiterated Rating | B. Riley | Buy | $17.25 |
| 2015-12-28 | Reiterated Rating | Oppenheimer | Buy | $25.00 |
| 2015-12-28 | Lower Price Target | B. Riley | Buy | $19.50 to $17.25 |
| 2015-11-30 | Reiterated Rating | Oppenheimer | Outperform | $25.00 |
| 2015-11-11 | Reiterated Rating | Oppenheimer | Outperform | $25.00 |
| 2015-11-09 | Lower Price Target | B. Riley | Buy | $19.75 to $19.50 |
| 2015-11-04 | Reiterated Rating | B. Riley | Buy | $19.75 to $19.50 |
| 2015-11-03 | Lower Price Target | Stifel Nicolaus | Buy | $25.00 to $23.00 |
| 2015-11-02 | Lower Price Target | Jefferies Group | Hold | $19.00 to $17.00 |
| 2015-08-31 | Reiterated Rating | B. Riley | Buy | $22.00 |
| 2015-08-26 | Reiterated Rating | B. Riley | Buy | $22.00 |
| 2015-08-17 | Reiterated Rating | B. Riley | Buy | $22.00 |
| 2015-08-12 | Reiterated Rating | B. Riley | Buy | $25.00 to $22.00 |
| 2015-08-12 | Lower Price Target | BB&T Corp. | Buy | $30.00 to $24.00 |
| 2015-08-05 | Lower Price Target | Stifel Nicolaus | Buy | $30.00 to $27.00 |
| 2015-07-21 | Reiterated Rating | Oppenheimer | Buy | $25.00 |
| 2015-05-18 | Reiterated Rating | Jefferies Group | Hold | $17.00 to $19.00 |
| 2015-05-08 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $17.00 to $25.00 |
| 2015-05-08 | Reiterated Rating | B. Riley | Buy | $25.00 |
| 2015-04-22 | Reiterated Rating | B. Riley | Buy | $25.00 |
| 2015-03-03 | Reiterated Rating | B. Riley | Buy | $19.50 |
| 2015-02-25 | Set Price Target | Oppenheimer | Buy | $25.00 |
| 2015-02-24 | Reiterated Rating | B. Riley | Buy | $19.50 |
| 2015-02-13 | Reiterated Rating | B. Riley | Buy | $19.50 |
| 2015-02-11 | Lower Price Target | Jefferies Group | Hold | $19.00 to $17.00 |
| 2015-02-10 | Reiterated Rating | Oppenheimer | Outperform | $25.00 |
| 2015-02-06 | Reiterated Rating | B. Riley | Buy | $21.00 |
| 2015-01-16 | Reiterated Rating | B. Riley | Buy | $21.00 |
| 2014-10-15 | Initiated | Stifel | Buy | $23 |
| 2014-10-15 | Initiated Coverage | Stifel Nicolaus | Buy | $23.00 |
| 2014-08-28 | Reiterated Rating | B. Riley | Buy | $21.50 to $22.00 |
| 2014-07-22 | Boost Price Target | BB&T Corp. | Buy | $22.00 to $24.00 |
| 2014-04-11 | Boost Price Target | Oppenheimer | Outperform | $23.00 to $25.00 |
| 2014-02-26 | Boost Price Target | Oppenheimer | Outperform | $19.00 to $23.00 |
| 2013-11-05 | Boost Price Target | BB&T Corp. | Buy | $18.00 to $20.00 |
| 2013-11-05 | Boost Price Target | Oppenheimer | Outperform | $17.00 to $19.00 |
| 2013-11-01 | Boost Price Target | Jefferies Group | Hold | $13.50 to $16.50 |
| 2013-09-16 | Upgrade | B. Riley | Neutral to Buy | |
| 2013-09-13 | Upgrade | BB&T Capital Mkts | Hold to Buy | $18 |
| 2012-02-07 | Reiterated | Auriga | Buy | $17 to $20 |
| 2011-09-09 | Initiated | KeyBanc Capital Mkts | Hold | |
| 2010-05-21 | Initiated | Oppenheimer | Outperform | $17 |
| 2009-11-24 | Initiated | B. Riley & Co | Buy | |
| 2009-10-09 | Initiated | Credit Suisse | Outperform | $11 |
| 2016-06-13 | Upgrade | Jefferies Group | Hold to Buy | $19.00 to $11.00 |
| 2016-05-25 | Reiterated Rating | B. Riley | Buy | $12.50 |
| 2016-05-20 | Reiterated Rating | B. Riley | Buy | $12.50 |
| 2016-03-21 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $19.00 to $14.00 |
| 2016-02-09 | Reiterated Rating | Oppenheimer | Outperform | $25.00 to $16.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In GSM 82 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| COOPER CREEK PARTNERS MANAGEMENT LLC | 7.63M |
| CANNELL PETER B & CO INC | 4.70M |
| Marshall Wace LLP | 4.46M |
| Boston Partners | 3.27M |
| Halcyon Management Partners LP | 3.17M |
| RENAISSANCE TECHNOLOGIES LLC | 3.07M |
| Nokomis Capital, L.L.C. | 2.50M |
| DIMENSIONAL FUND ADVISORS LP | 2.46M |
| Park West Asset Management LLC | 2.40M |
| MARSHALL WACE ASIA Ltd | 2.38M |
| ROYCE & ASSOCIATES LLC | 2.31M |
| BlackRock Fund Advisors | 1.94M |
| MASTERS CAPITAL MANAGEMENT LLC | 1.90M |
| MASON CAPITAL MANAGEMENT LLC | 1.35M |
| OPPENHEIMER FUNDS INC | 1.27M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Bradley Jeff Chief Executive Officer | 0.05% (40000) | FRTA / GSM / |
| Appelbaum Malcolm Chief Financial Officer | 0.01% (7307) | GSM / |
UM